10x Genomics (TXG) Other Non-Current Assets (2018 - 2026)

10x Genomics has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $15.3 million for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 472.48% year-over-year to $15.3 million; the TTM figure through Jun 2026 stood at $15.3 million (up 472.48% YoY), while the FY2025 annual figure was $2.9 million, down 29.45% from the prior year.
• Other Non-Current Assets came in at $15.3 million for Q2 2026 at 10x Genomics, up from $2.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.0 million in Q4 2023 to a low of $1.9 million in Q3 2025.
• Average Other Non-Current Assets over 5 years is $9.6 million, with a median of $4.9 million recorded in 2024.
• Year-over-year, Other Non-Current Assets tumbled 93.23% in 2024 and surged 472.48% in 2026.
• Over 5 years, Other Non-Current Assets stood at $7.1 million in 2022, then soared by 759.96% to $61.0 million in 2023, then plunged by 93.23% to $4.1 million in 2024, then retreated by 29.45% to $2.9 million in 2025, then soared by 425.51% to $15.3 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $15.3 million in Q2 2026, $2.6 million in Q1 2026, and $2.9 million in Q4 2025.